Long Term Extension Trial of setmelanotide (RM-493) for patients who have completed a trial of Setmelanotide for the treatment of obesity associated with genetic defects upstream of the MC4 receptor in the leptin-melanocortin pathway
Clinical Trial Grant
Administered By
Pediatrics, Endocrinology
Awarded By
RHYTHM PHARMACEUTICALS, INC.
Start Date
July 28, 2020
End Date
July 31, 2025
Administered By
Pediatrics, Endocrinology
Awarded By
RHYTHM PHARMACEUTICALS, INC.
Start Date
July 28, 2020
End Date
July 31, 2025